The global pharmaceutical industry is facing a surge biologics. In recent years, biologic drugs have enjoyed a better approval rating than traditional drugs, as biologic drugs have been found to treat major chronic and complex diseases with higher safety and efficacy. The global production of biologics is expected to grow at a rate of around 10% annually.Continue reading
Southeast Asia is the fastest growing pharmaceutical market in the world, witnessing strong double-digit growth since 2011, with growth of excipients consumption in the region also strong and estimated to increase at a compound annual growth rate of 13.4% through 2020, finds recently published Specialty Excipients for Oral Solid-Dosage-Form Pharmaceuticals: Emerging Markets Analysis and Opportunities by global market research and management consulting firm Kline. Another excipients market analyzed in the report with solid pockets of opportunity is the Middle East and Africa region, forecast to progress at nearly 8% through 2020.Continue reading
The global economy is experiencing severe turmoil for a host of reasons; including the massive drop in the price of oil, the slowdown in growth in China, the concerns about lending and real estate bubbles in China, the economic and financial struggles in Europe, emerging economy travails, and geopolitical challenges in the Middle East.Continue reading
Kline, a respected provider of world-class consulting services and high-quality market intelligence, today announced recent additions to the company’s executive team. Kline is proud to announce the appointments of Annie Jarquin as Director in the Energy Practice and Hardeep Parmar as Director in the Chemicals Practice of Kline’s Management Consulting business. Their respective experience will help to strengthen Kline’s abilities, reputation, and, most importantly, add value for our clients within the energy/lubricants and chemicals industries.Continue reading
Europe and CIS together account for a total 23% of the global synthetic latex polymers market in 2014. While consumption of synthetic latex polymers in CIS remains low, the region offers high growth potential. Import substitution programs implemented by the Russian government along with the strategic development of chemical industry plans across the majority of CIS countries will drive the synthetic latex market in the region, estimated to increase at 2.6% through 2019,finds the recently published analysis of the CIS and European regions from Kline’s Synthetic Latex Polymers: Global Business Analysis and Opportunities report. However, the political and economical instability in the region could decelerate this growth.
The markets for HI&I ingredients in the United States, China, and India—the three regions from the upcoming global HI&I ingredients report—are rather diverse in terms of growth, value, and volume. While there are differences in the size of these markets and their growth potentials, qualitative attributes also differ widely.
The consumption of ingredients in all three countries represents a large chunk of the total market, accounting for over USD 10 billion, driven by the United States, which represents more than half of this total. In terms of future outlook, India is forecast to post the strongest growth among these three countries, of almost 13% during the forecast period of 2014-2019. Continue reading
With approximately 90% of the active pharmaceutical ingredients that are under development falling into the two low solubility classes of the Biopharmaceutical Classification System (BCS), solubility enhancement technologies represent a strongly growing need for the pharmaceutical industry globally. Our current research covering solubility enhancement technologies and the related excipients market forecasts a compound annual growth rate (CAGR) of over 10% in the period from 2014 to 2024 for this highly important segment, driven by the demand for solubility enhancement excipients. Continue reading
Poor solubility has been a major challenge in the formulation development for oral solid dosage form (OSDF) pharmaceuticals, a preferred route for pharmaceutical consumption. Various methods have been researched to improve solubility of poorly soluble API and among these the use of polymers for solubility enhancement in solid dispersions is among the most popular. Identifying the importance of the trend and to fulfill inadequately assessed market for polymers for solubility enhancement, global consulting and research firm Kline & Company is announcing the undertaking of a comprehensive study on Polymers for Solubility Enhancement in Pharmaceutical Oral Solid Dosage Forms: Global Market Analysis and Opportunities. The study will cover current and forecast demand by major products, supplier sales, and technical and market trends, as well as market opportunities and challenges for manufacturers of these polymers worldwide.Continue reading
Complex combination of factors are driving the market of specialty excipients for OSDF globally
On a global scale, the oral solid dosage form (OSDF) excipients market is growing sustainably, historically exhibiting a robust increase. This market is valued at nearly $2.3 billion in the United States, Europe, India, and China, according to recently published Specialty Excipients for Oral Solid Dosage Form Pharmaceuticals Global Series: Business Analysis and Opportunities by worldwide consulting and research firm Kline & Company.Continue reading
Consisting of a 10 million dry tonne, USD 30 billion+ market, the global synthetic latex polymers (SLP) market is a sizeable one. Although the North America and European markets remain the largest consumers of synthetic latex polymers, claiming some 56% of global volume, strong shifts are being seen in markets as diverse as China, India, and the Middle East according to recent findings within the Synthetic Latex Polymers Global Series: Business Analysis and Opportunities report by international market research and management consulting firm Kline & Company.Continue reading